Listen "Navigating Chronic Hand Eczema"
Episode Synopsis
Disclaimer: This podcast is not sponsored by or associated with any of the products mentioned in today's episode.In this episode of Skinfluenced: The Skin Podcast, we’re shining a spotlight on Chronic Hand Eczema (CHE). With the recent approval the first topical treatment for moderate to severe chronic hand eczema, we want to brush everyone up on CHE.Tune in to discover how this new medication, a topical Janus kinase (JAK) inhibitor, performs against placebo in improving chronic hand eczema. We discuss the clinical benefits, safety profile, and what this means for patients struggling with persistent hand eczema despite conventional therapies.Link to Source(s):Mense SA, Maher S, & Chovatiya RA. A Practical Approach to Chronic Hand Eczema: https://rdcu.be/ey3d5#ChronicHandEczema #CHE #Delgocitinib #JAKInhibitor #HandDermatitis #FDAApproval #InflammatorySkinDisease #TopicalJAKInhibitor #OccupationalEczema #SkinBarrierRepair #SkinScience #Dermatology #DermatologyProvider #Dermatologist #CosmeticDermatology #Aesthetics #PhysicianAssistant #PhysicianAssociate #NursePractitioner #DermatologyPodcast #SkinfluencedPodcast
More episodes of the podcast Skinfluenced - The Skin Podcast
Press Release: Libtayo (Cemiplimab) Approved as First Adjuvant Immunotherapy for High-Risk cSCC
23/10/2025
Press Release: Zoryve (roflumilast) 0.05% Cream Approved for Atopic Dermatitis in Ages 2-5
08/10/2025
Press Release: Opzelura (ruxolitinib) 2% Cream Approved for Atopic Dermatitis in Ages 2 and Up
21/09/2025
Just Released! Is PDGF Safe?
09/09/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.